Laval, Canada

Bruno Haché

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim (Canada) Ltd.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Haché. Retrieved from https://idiyas.com/inventor/bruno-hachandeacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bruno Haché

Introduction

Bruno Haché is a notable inventor based in Laval, Canada. He has made significant contributions to the field of medical research, particularly in the development of inhibitors for the papilloma virus. His work has implications for the treatment and prevention of viral infections.

Latest Patents

Bruno Haché holds 1 patent related to inhibitors of the papilloma virus. This patent showcases his innovative approach to tackling viral challenges and highlights his commitment to advancing medical science.

Career Highlights

Haché is currently employed at Boehringer Ingelheim (Canada) Ltd., where he continues to engage in groundbreaking research. His role at the company allows him to collaborate with other experts in the field and contribute to the development of effective medical solutions.

Collaborations

Some of his notable coworkers include Christiane Yoakim and Jeffrey O'Meara. Their collective expertise enhances the research environment and fosters innovation within the company.

Conclusion

Bruno Haché's work exemplifies the spirit of innovation in the medical field. His contributions to the development of papilloma virus inhibitors are a testament to his dedication and expertise.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…